NCT00005007 - Etanercept for Wegener's Granulomatosis | Biotech Hunter

Enrollment

181

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

Wegener's Granulomatosis

Interventions

DRUG

Etanercept

Trial Locations (8)

Beth Israel Medical Center, New York

Johns Hopkins University, Baltimore

Duke University, Durham

Cleveland Clinic Foundation, Cleveland

University of Michigan, Ann Arbor

Mayo Clinic, Rochester

University of California, San Francisco, San Francisco

Boston University, Boston

All Listed Sponsors

collaborator

FDA Office of Orphan Products Development

FED

lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH